Novo Nordisk
NVO
#33
Rank
$221.76 B
Marketcap
$97.93
Share price
-0.39%
Change (1 day)
-2.75%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2022 (TTM): $10.00 B

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are $10.00 B. In 2021 the company made an earning of $9.29 B an increase over its 2020 earnings that were of $8.26 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$10.00 B7.71%
2021$9.29 B12.47%
2020$8.26 B13.07%
2019$7.30 B-3.35%
2018$7.55 B1.79%
2017$7.42 B4.52%
2016$7.10 B9.42%
2015$6.49 B8.24%
2014$5.99 B3.45%
2013$5.79 B19.02%
2012$4.87 B15.21%
2011$4.22 B17.71%
2010$3.59 B24.78%
2009$2.87 B16.62%
2008$2.46 B47.95%
2007$1.66 B7.07%
2006$1.55 B18.18%
2005$1.31 B13.43%
2004$1.16 B
2002$0.84 B-14.39%
2001$0.98 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$33.77 B 237.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.22 B-37.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.45 B-5.51%๐Ÿ‡ซ๐Ÿ‡ท France
$7.66 B-23.46%๐Ÿ‡บ๐Ÿ‡ธ USA